Size-exclusion chromatography comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-05-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Stability depends on moisture, temperature, oxygen, and packaging. Dry collagen peptide powders are generally stable when kept cool and dry, but humid conditions can cause clumping and microbial growth. Heat exposure may promote Maillard reactions if reducing sugars are present, altering color and flavor. Solutions are less stable than powders and may support microbial proliferation unless preserved or refrigerated; light exposure can also affect appearance over time. Shelf-life claims vary and should be supported by real-time or accelerated stability data.
Quality control for collagen peptides may include identity, purity, and contaminant testing. Identity can be supported by amino acid profile and hydroxyproline content; purity checks may examine moisture, ash, protein content, and peptide size range. Heavy metals, microbial counts, and residual solvents are relevant for materials intended for ingestion. Some suppliers use peptide fingerprinting or source-specific markers, though these methods are not universally standardized. Documentation such as certificates of analysis helps verify that a batch meets agreed specifications.
Identity and purity testing for collagen peptides combines general protein assays with methods sensitive to collagen-specific features. Hydroxyproline content is often measured colorimetrically after acid hydrolysis and serves as a marker of collagen origin. Total nitrogen or Kjeldahl analysis estimates protein content but does not distinguish peptides from other nitrogenous compounds. Amino acid analysis provides a compositional fingerprint, while SDS-PAGE and size-exclusion chromatography reveal molecular weight ranges. No single method captures all quality attributes, so specifications typically combine several orthogonal tests.
Molecular weight distribution is a central quality attribute because it influences solubility, viscosity, foaming, and sensory properties. High-performance size-exclusion chromatography with refractive index or multi-angle light scattering detection can estimate average molecular weight and polydispersity. The degree of hydrolysis is sometimes measured by quantifying free amino groups with trinitrobenzenesulfonic acid or o-phthalaldehyde. Results depend on calibration standards and mobile-phase conditions, so method details matter when comparing certificates of analysis. Reported values are operational rather than absolute unless the method is fully validated.
Collagen peptides are hygroscopic and can cake or lose flowability when exposed to moisture. Typical storage is in sealed containers at ambient temperature, away from direct sunlight and strong odors. High humidity and prolonged heat may increase Maillard browning, off-odors, or microbial risk. Food-grade specifications commonly set limits for moisture, ash, heavy metals, and total plate count. Stability studies often monitor appearance, moisture, molecular mass profile, and microbial counts over defined intervals.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | 15–25 °C | Keep dry and protect from direct light |
| Moisture content | ≤ 6–8% | Higher moisture can reduce stability |
| Solubility class | Water-soluble | Insoluble in nonpolar solvents |
| Common analytical method | Size-exclusion chromatography | Used for molecular weight distribution |
| Microbial limits | Total aerobic count < 10³ CFU/g | Specifications vary by market and application |
Analytical methods for collagen peptides focus on molecular weight distribution, amino acid composition, and purity. Size exclusion chromatography with UV detection is widely used to estimate molecular weight ranges. High-performance liquid chromatography can quantify hydroxyproline after acid hydrolysis. Mass spectrometry provides detailed sequence information for individual peptides. Other tests include moisture content, ash, heavy metals, and microbial limits. The choice of method depends on the specific quality attribute and the required sensitivity.
Storage and handling of collagen peptides require protection from moisture, heat, and light. The powders are hygroscopic and can absorb water from the air, leading to clumping or microbial growth. Typical storage conditions are a cool, dry place at room temperature or below, in tightly sealed containers. Some manufacturers recommend refrigeration for long-term stability. Solutions prepared from the powder are less stable and should be used promptly or preserved according to validated protocols.
Production of collagen peptides begins with raw materials such as bovine hide, porcine skin, fish scales, or poultry cartilage. The collagen is extracted, often with acid or alkaline treatment, and then subjected to hydrolysis using enzymes like pepsin or alcalase, or chemical agents. Enzymatic hydrolysis is favored for its mild conditions and controllability. The resulting mixture is filtered, concentrated, and dried to yield a powder. Process parameters such as temperature, pH, and enzyme-to-substrate ratio determine the molecular weight profile and yield.
Quality control for collagen peptides includes measurements of moisture content, ash, protein content, and heavy metals. Microbial limits are set to ensure food or cosmetic grade safety, and the degree of hydrolysis serves as a key process indicator. That indicator correlates with molecular weight distribution and solubility characteristics. Regulatory requirements vary by country, and some jurisdictions restrict label claims about health effects. Documentation such as certificates of analysis and safety data sheets typically accompanies commercial shipments of the material.
Analytical testing of collagen peptides focuses on identity, purity, and molecular weight profile. Size-exclusion chromatography separates peptides by hydrodynamic volume and is often calibrated with known protein standards. Amino acid analysis after acid hydrolysis provides the compositional profile, which can confirm the collagen origin. Mass spectrometry offers detailed sequence information for individual peptides. These methods together help ensure that a product matches its specification and that batch-to-batch variability is controlled.
Dry collagen peptide powder is generally stable when kept in a sealed container away from moisture, heat, and direct sunlight. The powder is hygroscopic and can clump if exposed to humid air, so desiccant packets are sometimes included. In solution, collagen peptides are susceptible to microbial growth unless preserved or refrigerated. Prolonged exposure to high temperatures may cause aggregation or color changes. Typical storage recommendations are cool and dry conditions at ambient temperature.
==== EPS in building construction ==== Sheets of EPS are commonly packaged as rigid panels (common in Europe is a size of 100 cm x 50 cm, usually depending on an intended type of connection and glue techniques, it is, in fact, 99.5 cm x 49.5 cm or 98 cm x 48 cm; less common is 120 x 60 cm; size 4 by 8 ft (1.2 by 2.4 m) or 2 by 8 ft (0.61 by 2.44 m) in the United States). Common thicknesses are from 10 mm to 500 mm. Many customizations, additives, and thin additional external layers on one or both sides are often added to help with various properties. An example of this is lamination with cement board to form a structural insulated panel. Thermal conductivity is measured according to EN 12667. Typical values range from 0.032 to 0.038 W/(m⋅K) depending on the density of the EPS board. The value of 0.038 W/(m⋅K) was obtained at 15 kg/m3 while the value of 0.032 W/(m⋅K) was obtained at 40 kg/m3 according to the datasheet of K-710 from StyroChem Finland. Adding fillers (graphites, aluminum, or carbons) has allowed the thermal conductivity of EPS to reach around 0.030–0.034 W/(m⋅K) (as low as 0.029 W/(m⋅K)) and as such has a grey/black color which distinguishes it from standard EPS. Several EPS producers have produced a variety of these increased thermal resistance EPS usage for this product in the UK and EU. Water vapor diffusion resistance (μ) of EPS is around 30–70. ICC-ES (International Code Council Evaluation Service) requires EPS boards used in building construction meet ASTM C578 requirements.
Gestation in bats ranges from around 40 days to eight months, correlating with the size of the species. In most bat species, females carry and give birth to a single pup per litter. A newborn bat pup can be up to 40 percent of the mother's weight, and the pelvic girdle of the female can expand during birth as the two halves are connected by a flexible ligament. Females typically give birth upright or horizontally, using gravity to make the process easier. The young emerges rear-first, possibly to prevent the wings from becoming tangled, and the female holds it in her wing and tail membranes. In many species, females give birth and raise their young in maternity colonies and may assist each other in birthing. Most of the care for a young bat comes from the mother, though in monogamous species, the father plays a role. Allo-suckling, where a female suckles another mother's young, occurs in several species. This may serve to increase colony size in species where females breed in their birth colonies. Young bats can fly after they develop their adult body dimensions and forelimb length. For the little brown bat, this occurs when they are eighteen days old. Weaning of young for most species takes place in under 80 days. The common vampire bat nurses its offspring beyond that, and young vampire bats achieve independence later in life than other species. This is probably due to the species's blood-based diet, as the female may not be able to feed on a nightly basis.
The medio-lateral incision is made between the vagina at an angle and is not as likely to tear through to the anus. The medio-lateral cut takes more time to heal than the median cut. Vaginectomy is surgery to remove all or part of the vagina, and is usually used to treat malignancy. Removal of some or all of the sexual organs can result in damage to the nerves and leave behind scarring or adhesions. Sexual function may also be impaired as a result, as in the case of some cervical cancer surgeries. These surgeries can impact pain, elasticity, vaginal lubrication and sexual arousal. This often resolves after one year but may take longer. Women, especially those who are older and have had multiple births, may choose to surgically correct vaginal laxity. This surgery has been described as vaginal tightening or rejuvenation. While a woman may experience an improvement in self-image and sexual pleasure by undergoing vaginal tightening or rejuvenation, there are risks associated with the procedures, including infection, narrowing of the vaginal opening, insufficient tightening, decreased sexual function (such as pain during sexual intercourse), and rectovaginal fistula. Women who undergo this procedure may unknowingly have a medical issue, such as a prolapse, and an attempt to correct this is also made during the surgery. Surgery on the vagina can be elective or cosmetic. Women who seek cosmetic surgery can have congenital conditions, physical discomfort or wish to alter the appearance of their genitals.
Sources: en.wikipedia.org
== Treatment == Early and effective treatment of acne scarring can prevent severe acne and the scarring that often follows. In 2004, no prescription drugs for the treatment or prevention of scars were available.
=== Excessive sugar intake === Too much sugar intake can negatively impact the body, including damage to collagen. Excess sugar consumption results in glycation that produces AGEs. This occurs naturally, and when too much sugar is consumed, the AGE molecules stick to the collagen molecules turning them stiff, thus damaging them. The process of glycation does not only damage the collagen existing in the body but also makes some alterations to its stability. When an individual consumes excessive amounts of sugar, the glycation process converts collagen into an unstable type 1, which becomes more vulnerable and can be easily broken down, potentially leading to premature aging.
=== Technetium === The first element to be synthesized, rather than discovered in nature, was technetium in 1937. This discovery filled a gap in the periodic table, and the fact that technetium has no stable isotopes explains its natural absence on Earth (and the gap). With the longest-lived isotope of technetium, 97Tc, having a 4.21-million-year half-life, no technetium remains from the formation of the Earth. Only minute traces of technetium occur naturally in Earth's crust—as a product of spontaneous fission of 238U, or from neutron capture in molybdenum—but technetium is present naturally in red giant stars.
== History == Insulin was discovered by Sir Frederick G Banting, Charles H Best, and JJR Macleod from the University of Toronto in 1921 as an injectable agent. German researchers first introduced the idea of inhalable insulin in 1924. Years of failure followed until scientists realized they might be able to use new technologies to turn insulin into a concentrated powder with particles sized for inhalation. In the 1980s Nektar Therapeutics, based on work by A. Carl Leopold on vitrifying proteins, developed technology to make insulin into small particles, technology then licensed to Pfizer. Alkermes developed a delivery device that they licensed to Eli Lilly and Company. Once concrete methods were developed, human tests began in the late 1990s. In January 2006, the U.S. Food and Drug Administration (FDA) approved the use of Exubera, a form of inhalable insulin developed by Pfizer. It was approved in the UK in August 2006 but reimbursed by the National Health Service only for people who had problems with needles. It was not reimbursed by any U.S. insurer. A 2007 systematic review concluded that the inhaled hexameric insulin (Exubera) "appears to be as effective, but no better than injected short-acting insulin. The additional cost is so much more that it is unlikely to be cost-effective." In 2007, Pfizer announced that it would no longer manufacture or market Exubera. According to Chairman and CEO Jeffrey Kindler this was because Exubera "failed to gain acceptance among patients and physicians".
Sources: en.wikipedia.org
== First generation GcMAF == Gc protein-derived macrophage-activating factor (GcMAF). GcMAF initially conceptualized by Nobuto Yamamoto in 1991, has been researched as a possible cancer treatment. Previous research efforts involved the isolation of Gc protein (1f1f subtype) from human serum through an affinity column modified with 25-hydroxyvitamin D3. GcMAF was enzymatically derived from the isolated Gc protein.
Enzyme structures may also contain allosteric sites where the binding of a small molecule causes a conformational change that increases or decreases activity. A small number of RNA-based biological catalysts called ribozymes exist, which again can act alone or in complex with proteins. The most common of these is the ribosome which is a complex of protein and catalytic RNA components.
== Composition == The characteristic substances inside the extracellular matrix of soft tissue are the collagen, elastin and ground substance. Normally the soft tissue is very hydrated because of the ground substance. The fibroblasts are the most common cell responsible for the production of soft tissues' fibers and ground substance. Variations of fibroblasts, like chondroblasts, may also produce these substances.
Propranolol is occasionally used to treat performance anxiety, although evidence to support its use in any anxiety disorders is poor. Its efficacy in managing panic disorder appears similar to benzodiazepines, while carrying lower risks for addiction or abuse. Although beta blockers such as propranolol have been suggested to be beneficial in managing physical symptoms of anxiety, its efficacy in treating generalized anxiety disorder and panic disorder remain unestablished. It is thought that beta blockers do not directly treat psychological symptoms of anxiety, but can help control physical symptoms such as palpitations and tremors. This may interfere with a positive feedback loop to indirectly reduce psychological anxiety. A 2025 systematic review and meta-analysis found widespread prescription of beta blockers, namely propranolol, for treatment of anxiety disorders, but found no evidence of a beneficial effect relative to placebo or benzodiazepines in people with social phobia or panic disorder. However, the quality of evidence, including both numbers of studies and patients as well as quality and risk of bias of those studies, was limited. Findings were similar in a previous 2016 systematic review and meta-analysis. Other beta blockers that have been used to treat anxiety disorders besides propranolol include atenolol, betaxolol, nadolol, oxprenolol, and pindolol. Some experimentation has been conducted in other psychiatric areas:
Marmite ( MAR-myte) is a food spread produced in New Zealand by Sanitarium Health and Wellbeing Company and distributed in Australia and the Pacific. It is similar to the British Marmite, but the two products are made by different companies. This is the only product sold as Marmite in Australasia and the Pacific, whereas elsewhere in the world the British version predominates. In the rest of the world it is sold as "NZ-Mite". Marmite has been manufactured in New Zealand since 1919. The product's popularity in England prompted the Sanitarium Health Food Company to obtain sole rights to distribute the product in New Zealand and Australia in 1908. They later began manufacturing Marmite under licence in Christchurch, albeit using a modified version of the original recipe, most notable for its inclusion of sugar and caramel. Common ingredients are also slightly different quantities from the British version; the New Zealand version has high levels of potassium, for example. New Zealand Marmite is described as having a "weaker" or "less tangy" flavour than the British version.
Sources: en.wikipedia.org
Common methods include size-exclusion chromatography and mass spectrometry. Amino acid analysis provides composition data but not chain length. Results depend on calibration standards and sample preparation.
A cool, dry place protected from moisture and direct light is typical. Sealed containers help prevent clumping and contamination. Solution forms usually require refrigeration or preservatives.
It may report appearance, moisture, ash, protein content, molecular weight distribution, and microbial limits. Heavy metal results and amino acid profiles are also common. The exact panel depends on the supplier and intended use.
Purity is assessed through a combination of protein content, hydroxyproline, amino acid composition, and chromatographic profile. Moisture, ash, and microbial tests cover non-protein impurities and handling quality.